Creyon
United States · $40.0M raised
- Business Model
- B2B
- Website
- creyon.com
- Total Funding
- $40.0M
- Last Round
- Series AMar 2022
- Rounds
- 1
About
AI-driven drug development company creating tissue-specific RNA-targeted oligonucleotide medicines.
Summary
Creyon is an Artificial Intelligence company based in United States. It has raised $40.0M in total across 1 round, most recently a Series A round in Mar 2022. Investors include DCVC (Data Collab), Lux Capital and Casdin Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.